The MM Trials will probably be the most expensive

The MM Trials will probably be the most expensive trials to run of all that OWCP is planning to undertake. I say this because unlike the cream or sublingual tablet where the judgement of what the product is doing ought to be relatively easy to observe, in MM the trial will probably involve hundreds of patients where they're observed over a period of years to determine the benefit over a substantial period of time. I would hope that OWCP gains a big Pharma partner in doing such a trial, and while the big Pharma would get the lion's share of the earnings, they would also be responsible for the entire cost of the trial.

I know people who are in remission for MM, so current treatments certainly do work for many people, but like the leukemia I'm being treated for, they are routinely monitored to determine the disease is remaining in remission.

I'm uncertain, but I believe that the company sees MM as just the first form of cancer that they believe can be benefited by treatment with certain cannabis extracts, I believe that it may have much broader potential. The good news is that I think the benefits will come from the sublingual tablet and while the forms marketed without full clinical testing might not be precisely the same as what may be used in clinical trials, I believe that evidence may suggest to many cancer patients that it's use may be of benefit. One thing is almost certain, it can benefit cancer patients who are losing weight in an uncontrollable way, cancer cachexia is the name given to that. Personally I lost a lot of weight when undergoing hospital treatment, however I put more of the blame on the food served in the hospital than the disease. I didn't take long to put the weight back on with home cooking and eating out.

Doctor's may be hesitant to suggest cannabis but with the Federal Govt. backing off on policing it, it will depend it it's permitted in the hospital's. I know when I was in the hospital the nurses feared any cannabis based product being found in the hospital as they could be cited for violating Federal law and lose funding for certain projects. I don't know that our sublingual tablets will ever be prescribed for use before it's an approved drug, and supplied by the hospital to patients, but if Doctor's encourage patients to use it, they could get it for themselves until it's approved as a drug.

It looks like the MM's brought the stock down at the close, and I would guess that they'll try to fill the $.435 gap at the open on Tuesday so as not to have the gap hanging over the stock.

Happy New Year's,

Gary